|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 116, Issue 4 1175-1183, Copyright © 1992 by Company of Biologists
JOURNAL ARTICLES |
V Nurcombe, N Fraser, E Herlaar and JK Heath
Department of Biochemistry, University of Oxford, UK.
MK is a gene encoding a secreted heparin-binding polypeptide originally isolated by differential screening for genes induced by retinoic acid (RA) in HM-1 embryonal carcinoma cells. Here we report that MK is expressed at high levels in both embryonal carcinoma and pluripotential embryonic stem cells and their differentiated derivatives. MK expression in these cell types is unaffected by the presence or absence of RA. Recombinant MK protein (rMK) was produced by transient expression in COS cells and purified by heparin affinity chromatography. rMK is a weak mitogen for 10T1/2 fibroblast cells but inactive as a mitogen for Swiss 3T3 fibroblasts. rMK is a potent mitogen for neurectodermal precursor cell types generated by treatment of 1009 EC cells with RA but has no mitogenic or neurotrophic effects on more mature 1009-derived neuronal cell types. rMK is active as an in vitro neurotrophic factor for E12 chick sympathetic neurons and its activity is markedly potentiated by binding the factor to tissue-culture plastic in the presence of heparin. Stable 10T1/2 cells lines have been established which express MK. These cells do not exhibit any overt evidence of cell transformation but extracellular matrix preparations derived from these cells are a potent source of MK biological activity. It is concluded that MK is a multifunctional neuroregulatory molecule whose biological activity depends upon association with components of the extracellular matrix.
This article has been cited by other articles:
|
|
 |
|
  M. Horiba, K. Kadomatsu, K. Yasui, J.-K. Lee, H. Takenaka, A. Sumida, K. Kamiya, S. Chen, S. Sakuma, T. Muramatsu, et al. Midkine Plays a Protective Role Against Cardiac Ischemia/Reperfusion Injury Through a Reduction of Apoptotic Reaction Circulation, October 17, 2006; 114(16): 1713 - 1720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Muramatsu, P. Zou, H. Suzuki, Y. Oda, G.-Y. Chen, N. Sakaguchi, S. Sakuma, N. Maeda, M. Noda, Y. Takada, et al. {alpha}4{beta}1- and {alpha}6{beta}1-integrins are functional receptors for midkine, a heparin-binding growth factor J. Cell Sci., October 15, 2004; 117(22): 5405 - 5415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Mashour, P. H. Driever, M. Hartmann, S. N. Drissel, T. Zhang, B. Scharf, U. Felderhoff-Muser, S. Sakuma, R. E. Friedrich, R. L. Martuza, et al. Circulating Growth Factor Levels Are Associated with Tumorigenesis in Neurofibromatosis Type 1 Clin. Cancer Res., September 1, 2004; 10(17): 5677 - 5683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Stoica, A. Kuo, C. Powers, E. T. Bowden, E. B. Sale, A. T. Riegel, and A. Wellstein Midkine Binds to Anaplastic Lymphoma Kinase (ALK) and Acts as a Growth Factor for Different Cell Types J. Biol. Chem., September 20, 2002; 277(39): 35990 - 35998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Vilar, C. Lalou, J.-P. Duong Van Huyen, S. Charrin, S. Hardouin, D. Raulais, C. Merlet-Benichou, and M. Lelievre-Pegorier Midkine Is Involved in Kidney Development and in Its Regulation by Retinoids J. Am. Soc. Nephrol., March 1, 2002; 13(3): 668 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Vacherot, J. Delbe, M. Heroult, D. Barritault, D. G. Fernig, and J. Courty Glycosaminoglycans Differentially Bind HARP and Modulate Its Biological Activity J. Biol. Chem., March 19, 1999; 274(12): 7741 - 7747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Ratovitski, P. T. Kotzbauer, J. Milbrandt, C. J. Lowenstein, and C. R. Burrow Midkine Induces Tumor Cell Proliferation and Binds to a High Affinity Signaling Receptor Associated with JAK Tyrosine Kinases J. Biol. Chem., February 6, 1998; 273(6): 3654 - 3660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kojima, T. Inui, H. Muramatsu, Y. Suzuki, K. Kadomatsu, M. Yoshizawa, S. Hirose, T. Kimura, S. Sakakibara, and T. Muramatsu Dimerization of Midkine by Tissue Transglutaminase and Its Functional Implication J. Biol. Chem., April 4, 1997; 272(14): 9410 - 9416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kojima, H. Muramatsu, H. Amanuma, and T. Muramatsu Midkine Enhances Fibrinolytic Activity of Bovine Endothelial Cells J. Biol. Chem., April 21, 1995; 270(16): 9590 - 9596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Nurcombe, C. E. Smart, H. Chipperfield, S. M. Cool, B. Boilly, and H. Hondermarck The Proliferative and Migratory Activities of Breast Cancer Cells Can Be Differentially Regulated by Heparan Sulfates J. Biol. Chem., September 22, 2000; 275(39): 30009 - 30018. [Abstract] [Full Text] [PDF]
|
|
